LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 932974
BOSTON, MA
Position in ALNY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$461,478
-$45,745 QoQ
Shares Held
1,533
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#477
of 764 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $43,678,237 across 12 Biotechnology names. ALNY ranks #3 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,875 | $41,075,697 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,317 | $1,647,653 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,533 | $461,478 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
500 | $268,475 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,000 | $77,400 | |
| 6 | OCUL |
Ocular Therapeutix, Inc
|
7,500 | $73,650 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
278 | $32,545 | |
| 8 | BNTX |
BioNTech SE
|
190 | $17,679 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $461,478 | 1,533 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $507,223 | 1,533 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $609,597 | 1,533 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $699,048 | 1,533 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $499,895 | 1,533 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $413,940 | 1,533 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $360,730 | 1,533 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $492,303 | 1,790 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $462,915 | 1,905 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $284,702 | 1,905 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $364,636 | 1,905 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $337,375 | 1,905 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $373,232 | 1,965 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $393,628 | 1,965 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $466,982 | 1,965 | Shares | Sole | 2023-03-02 | |
| 2022-09-30 | $393,314 | 1,965 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $286,595 | 1,965 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $330,662 | 2,025 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $343,399 | 2,025 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $382,340 | 2,025 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $346,159 | 2,042 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $289,015 | 2,047 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $263,189 | 2,025 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $294,840 | 2,025 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $299,922 | 2,025 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $220,421 | 2,025 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||